V. Molinier-frenkel et al., Adenovirus hexon protein is a potent adjuvant for activation of a cellularimmune response, J VIROLOGY, 76(1), 2002, pp. 127-135
The capacity of recombinant adenoviruses (rAd) to induce immunization again
st their transgene products has been well documented. In the present study,
we evaluated the vaccinal adjuvant role of rAd independently of its vector
function. BALB/c mice received one subcutaneous injection of a mixture of
six lipopeptides (LP6) used as a model immunogen, along with AdE1 degrees (
10(9) particles), a first-generation rAd empty vector. Although coinjected
with a suboptimal dose of lipopeptides, AdE1 degrees significantly improved
the effectiveness of the vaccination, even in the absence of booster immun
ization. In contrast to mice that received LP6 alone or LP6 plus a mock adj
uvant, mice injected with AdE1 degrees plus LP6 developed both a polyspecif
ic T-helper type I response and an effector CD8 T-cell response specific to
at least two class I-restricted epitopes. The helper response was still ob
served when immunization was performed using LP6 plus a mixture of soluble
capsid components released from detergent-disrupted virions. When mice were
immunized with LP6 and each individual capsid component, i.e., hexon, pent
on base, or fiber, the results obtained suggested that hexon protein was re
sponsible for the adjuvant effect exerted by disrupted Ad particles on the
helper response to the immunogen. Our results thus have some important impl
ications not only in vaccinology but also for gene therapy using rAd vector
s.